Clinical Trial Update: Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial updating escalating-dose melphalan with autologous stem cell support and amifostine cytoprotection across multiple cancers; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leukemia
• Lymphoma
• Neuroblastoma
• Ovarian Cancer
• Sarcoma

Drugs mentioned

• Amifostine (amifostine)
• Melphalan (Melphalan)

Snippet

Sponsor: University of Kentucky | Conditions: Breast Cancer, Leukemia | Phase 1, Phase 2 | Status: COMPLETED